Phase II study of the CPT‐11, mitoxantrone and dexamethasone regimen in combination with rituximab in elderly patients with relapsed diffuse large B‐cell lymphoma

Saved in:
Bibliographic Details
Published inCancer Science Vol. 97; pp. 933 - 937
Main Authors Mika Kohuri, Masami Bessho, Nozomi Niitsu, Masaaki Higashihara
Format Journal Article
LanguageJapanese
Published Wiley 29.06.2006
Subjects
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Camptothecin
Dexamethasone
Disease-Free Survival
Drug Resistance, Neoplasm
Female
Humans
Irinotecan
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Male
Mitoxantrone
Natriuretic Peptide, Brain
NM23 Nucleoside Diphosphate Kinases
Nucleoside-Diphosphate Kinase
Prognosis
Recurrence
Rituximab
Survival Analysis
Survival Rate
Treatment Outcome
Troponin T
Online AccessGet full text

Cover

More Information
ISSN:1347-9032
1349-7006
DOI:10.1111/j.1349-7006.2006.00249.x